Published in BMC Public Health on June 17, 2013
Putting health metrics into practice: using the disability-adjusted life year for strategic decision making. BMC Public Health (2013) 1.10
Applying the disability-adjusted life year to track health impact of social franchise programs in low- and middle-income countries. BMC Public Health (2013) 0.84
Introduction to use of health impact metrics for programmatic decision making in global health. BMC Public Health (2013) 0.75
Answering the question: are we making a difference? BMC Public Health (2013) 0.75
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Adherence to medication. N Engl J Med (2005) 39.77
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99
A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis (2001) 4.73
Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med (2009) 4.05
Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol (2010) 3.90
Effectiveness of condoms in preventing HIV transmission. Soc Sci Med (1997) 3.56
Interventions to improve water quality for preventing diarrhoea. Cochrane Database Syst Rev (2006) 1.93
Health impact assessment: a tool to help policy makers understand health beyond health care. Annu Rev Public Health (2007) 1.68
Diarrhoea and effects of different water sources, sanitation and hygiene behaviour in East Africa. Trop Med Int Health (2002) 1.54
Methods used in the Lives Saved Tool (LiST). BMC Public Health (2011) 1.48
Further epidemiological evaluation of a malaria model. Bull World Health Organ (1978) 1.37
Explaining inconsistencies between data on condom use and condom sales. BMC Health Serv Res (2005) 1.16
Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia. Stat Med (1995) 1.04
Situation analysis and epidemiology of infectious disease transmission: a South-East Asian regional perspective. Int J Environ Health Res (2003) 0.80
Mathematical models for decision-making in population and family planning. Am J Public Health (1971) 0.79
Costs and consequences of large-scale vector control for malaria. Malar J (2008) 2.93
Comparison of electronic data capture (EDC) with the standard data capture method for clinical trial data. PLoS One (2011) 2.06
Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog (2009) 1.81
Access to health care and mortality of children under 5 years of age in the Gambia: a case-control study. Bull World Health Organ (2009) 1.81
The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion (2004) 1.71
Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci (2006) 1.66
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol (2006) 1.62
An assessment of Lot Quality Assurance Sampling to evaluate malaria outcome indicators: extending malaria indicator surveys. Int J Epidemiol (2010) 1.53
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis (2007) 1.48
Determinants of bed net use in the Gambia: implications for malaria control. Am J Trop Med Hyg (2007) 1.45
Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun (2004) 1.41
Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr (2007) 1.36
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
Is mosquito larval source management appropriate for reducing malaria in areas of extensive flooding in The Gambia? A cross-over intervention trial. Am J Trop Med Hyg (2010) 1.29
Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS (2004) 1.26
Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 1.26
The role of communication between clients and health care providers: implications for adherence to malaria treatment in rural Gambia. Trop Med Int Health (2007) 1.24
Optimizing odor-baited trap methods for collecting mosquitoes during the malaria season in The Gambia. PLoS One (2009) 1.23
Determinants of provider choice for malaria treatment: experiences from The Gambia. Soc Sci Med (2008) 1.23
A simple approach to test for interaction between intervention and an individual-level variable in community randomized trials. Trop Med Int Health (2008) 1.18
Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Invest Ophthalmol Vis Sci (2010) 1.16
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology (2004) 1.15
Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? PLoS Med (2006) 1.13
Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health (2010) 1.10
Validity of verbal autopsy procedures for determining malaria deaths in different epidemiological settings in Uganda. PLoS One (2011) 1.07
Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect Immun (2010) 1.07
The association between refractive cutoffs for spectacle provision and visual improvement among school-aged children in South Africa. Br J Ophthalmol (2007) 1.06
Alternative treatments for indoor residual spraying for malaria control in a village with pyrethroid- and DDT-resistant vectors in the Gambia. PLoS One (2013) 1.03
Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One (2008) 1.02
Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis. Invest Ophthalmol Vis Sci (2010) 1.02
Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop? Clin Infect Dis (2006) 1.01
Field testing of different chemical combinations as odour baits for trapping wild mosquitoes in The Gambia. PLoS One (2011) 1.01
Meeting oxygen needs in Africa: an options analysis from the Gambia. Bull World Health Organ (2009) 0.97
Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Virol J (2008) 0.88
Applying the disability-adjusted life year to track health impact of social franchise programs in low- and middle-income countries. BMC Public Health (2013) 0.84
Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections? PLoS One (2012) 0.84
Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. Eur J Health Econ (2010) 0.84
A relational database for management of flow cytometry and ELISpot clinical trial data. Cytometry B Clin Cytom (2007) 0.82
Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years. Vaccine (2012) 0.82
Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia. PLoS One (2012) 0.79
Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis. BMC Genomics (2013) 0.78
Differential effects of frozen storage on the molecular detection of bacterial taxa that inhabit the nasopharynx. BMC Clin Pathol (2011) 0.78
Fit for prison: special population health and fitness programme evaluation. Int J Prison Health (2008) 0.78
The wider public health value of HCV treatment accrued by liver transplant recipients. Am J Manag Care (2016) 0.77
Bioactive TGF-beta levels can be preserved in plasma samples collected into heparin but not EDTA. Cytokine (2009) 0.76
Turning evidence into practice under payment reform: the new frontier of translational science. J Gen Intern Med (2014) 0.76
Achieving change in the NHS: a study to explore the feasibility of a home-based cancer chemotherapy service. Int J Nurs Stud (2004) 0.75
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. Int J Cardiol (2003) 0.75
The economics of TB control in developing countries. Expert Opin Pharmacother (2003) 0.75
Value of improved lipid control in patients at high risk for adverse cardiac events. Am J Manag Care (2016) 0.75